325 results
Page 4 of 17
8-K
kkc1f
27 Oct 14
Other Events
12:00am
8-K
EX-99.1
e03sgsgrm udsou
27 Oct 14
Other Events
12:00am
8-K
diddtgu2
21 Oct 14
Regulation FD Disclosure
12:00am
8-K
49h0qitrej7ww1 p2
17 Oct 14
Other Events
12:00am
8-K
EX-99
2c2j5s
17 Oct 14
Other Events
12:00am
8-K
EX-99.1
bcaqa4z
8 Sep 14
Other Events
12:00am
8-K
EX-99.5
31f25lm 6fu0n
8 Sep 14
Other Events
12:00am
8-K
EX-99.2
g76smz0rid6k3vj82
8 Sep 14
Other Events
12:00am
8-K
EX-99.4
sa6onf eajnncyv1uv
8 Sep 14
Other Events
12:00am
8-K
EX-99.1
vxttmdmu 54934xbpfq
9 Jul 14
Anoro® Ellipta® (umeclidinium/vilanterol) approved in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99
4lu1r
7 Jul 14
Other Events
12:00am
8-K
EX-99.1
nplqdb6ycils
21 May 14
Regulation FD Disclosure
12:00am
8-K
EX-99
llj85 5revho
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
m2vh qlrkh8chj
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.8
fgsl a6vvcjfs3yyv4jv
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
bcdqfi onxjzuq
9 Apr 14
Regulation FD Disclosure
12:00am